Chinese Network of Pediatric Antiretroviral Therapy

NCT01210924 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2018-03-30

No results posted yet for this study

Summary

This is an observational cohort in pediatric HIV patients in China. Children who receive antiretroviral drugs will be recruited in this study. The main objectives are as follows: 1. To establish simpler and smarter pediatric antiretroviral therapy in China including both first-line and second-line regimens. 2. To study the nature, characteristics and mechanisms of immunoreconstitution in HIV-infected children using the data and samples from the pediatric antiretroviral therapy cohort. 3. To establish a basic science and clinical research network based on the pediatric antiretroviral cohort.

Conditions

  • Acquired Immunodeficiency Syndrome

Sponsors & Collaborators

  • National Center for AIDS/STD Control and Prevention, China CDC

    lead OTHER_GOV

Principal Investigators

  • Fujie Zhang, MD · National Center for AIDS/STD control and prevention

Eligibility

Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01210924 on ClinicalTrials.gov